サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：医薬品販売受託機関の世界市場規模調査＆予測、サービス別（パーソナルプロモーション、非パーソナルプロモーション）、エンドユース別（製薬会社、バイオ医薬品会社）、地域分析、2022-2029年
市場調査レポート
商品コード
1262714

医薬品販売受託機関の世界市場規模調査＆予測、サービス別（パーソナルプロモーション、非パーソナルプロモーション）、エンドユース別（製薬会社、バイオ医薬品会社）、地域分析、2022-2029年

Global Pharmaceutical Contract Sales Organizations Market Size study & Forecast, by Service (Personal Promotion, Non-personal Promotion), by End-use (Pharmaceutical Companies, Biopharmaceutical Companies) and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
医薬品販売受託機関の世界市場規模調査＆予測、サービス別（パーソナルプロモーション、非パーソナルプロモーション）、エンドユース別（製薬会社、バイオ医薬品会社）、地域分析、2022-2029年
出版日: 2023年04月17日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医薬品販売受託機関市場は、2021年に約79億米ドルと評価され、予測期間2022-2029年には8.4%以上の健全な成長率で成長すると予測されています。

予防接種やその他の効率的な治療法の代替品の生産能力を拡大するために、医薬品部門は精査されるようになりました。これらの進歩は、消費者やヘルスケア施設の需要に応えるため、医薬品販売受託（CSO）分野の市場参入企業によって利用されています。医薬品販売受託（CSO）分野の市場参加者が収益を上げるもう一つの重要な要因は、免疫システムの潜在能力に関する知識の増加です。自社販売コストの低減に対する要望の高まり、医薬品の研究開発活動の活発化、新薬の発売数の増加は、業界拡大の主要な促進要因の一部です。さらに、政府の高い取り組みと老人人口の増加が、予測期間2022-2029年にかけて、市場に有利な成長機会を生み出しています。

バイオ医薬品を製造する企業は現在、研究能力の強化に注力しています。Pharma R&D annual reviewによると、2022年に開発中の全医薬品のほぼ45%がバイオ医薬品です。バイオ医薬品企業は、研究への関心が高いことから、営業活動をCSOに委託し、研究能力に集中することが予想されます。しかし、医薬品販売受託機関のコストが高いため、2022-2029年の予測期間を通じて市場の成長が阻害されます。

医薬品販売受託機関の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、世界のその他の地域です。2022年には、北米が最大の市場シェアを持ち、世界の業界収益の約34.45%を占めています。この地域の成長を促進する主な要因の1つは、IQVIA, Inc.、EPS Corp.、Axxelusを含む、相当数のCSOが存在することです。医薬品CSOの需要は、この地域が医薬品販売のための新技術を受け入れていることや、この地域で新薬が大量に発売されていることが、さらに後押ししています。予測期間中、アジア太平洋地域は最も速い速度で増加すると予測されています。この地域では、常に新しい治療法を開発している製薬会社やバイオ医薬品会社の数が非常に多いため、CSO業務の需要が高まっています。その他の新興国市場と比較して、同地域はCSOサービスを低コストで提供しているため、CSO活動の向上と同セクター市場の支援が期待されています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、競合情勢や主要企業のサービス内容の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 医薬品販売受託機関市場、地域別、2019-2029年
    • 医薬品販売受託機関市場、サービス別、2019-2029年
    • 医薬品販売受託機関市場、エンドユース別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 医薬品販売受託機関の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 世界の医薬品販売受託機関の市場力学

  • 医薬品販売受託機関市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 医薬品の研究開発活動の活発化
      • 成長する医薬品開発
    • 市場の課題
      • 医薬品受託販売組織の高コスト体質
    • 市場機会
      • 政府の高い取り組み
      • 老年人口の増加

第4章 世界の医薬品販売受託機関市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 投資採用モデル
  • アナリストの提言と結論
  • 主な投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 医薬品販売受託機関の世界市場：サービス別

  • マーケットスナップショット
  • 医薬品販売受託機関の世界市場：サービス別、業績別、ポテンシャル分析
  • 世界の医薬品販売受託機関市場のサービス別推定・予測2019-2029
  • 医薬品販売受託機関市場、サブセグメント別分析
    • パーソナルプロモーション
    • ノン・パーソナルプロモーション

第7章 医薬品販売受託機関の世界市場：エンドユース別

  • マーケットスナップショット
  • 医薬品販売受託機関の世界市場：エンドユース別、実績 - ポテンシャル分析
  • 世界の医薬品販売受託機関市場のエンドユース別推定・予測2019-2029
  • 医薬品販売受託機関市場、サブセグメント別分析
    • 製薬会社
    • バイオ製薬会社

第8章 医薬品販売受託機関の世界市場：地域別分析

  • 医薬品販売受託機関市場、地域別市場スナップショット
  • 北米
    • 米国
      • サービス別の推定・予測、2019年～2029年
      • エンドユース別の推定・予測、2019年～2029年
    • カナダ
  • 欧州医薬品販売受託機関市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の医薬品販売受託機関市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの医薬品販売受託機関市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • CMIC Holdings Co., Ltd.
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Axxelus
    • EPS Corp.
    • QFR Solutions
    • MaBico
    • Mednext Pharma Pvt. Ltd.
    • Peak Pharma Solutions Inc.
    • IQVIA, Inc.
    • Promoveo Health
    • Syneous Health

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Pharmaceutical Contract Sales Organizations Market, report scope
  • TABLE 2. Global Pharmaceutical Contract Sales Organizations Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Pharmaceutical Contract Sales Organizations Market estimates & forecasts by Service 2019-2029 (USD Billion)
  • TABLE 4. Global Pharmaceutical Contract Sales Organizations Market estimates & forecasts by End-use 2019-2029 (USD Billion)
  • TABLE 5. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Pharmaceutical Contract Sales Organizations Market
  • TABLE 70. List of primary sources, used in the study of global Pharmaceutical Contract Sales Organizations Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Pharmaceutical Contract Sales Organizations Market, research methodology
  • FIG 2. Global Pharmaceutical Contract Sales Organizations Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Pharmaceutical Contract Sales Organizations Market, key trends 2021
  • FIG 5. Global Pharmaceutical Contract Sales Organizations Market, growth prospects 2022-2029
  • FIG 6. Global Pharmaceutical Contract Sales Organizations Market, porters 5 force model
  • FIG 7. Global Pharmaceutical Contract Sales Organizations Market, pest analysis
  • FIG 8. Global Pharmaceutical Contract Sales Organizations Market, value chain analysis
  • FIG 9. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Pharmaceutical Contract Sales Organizations Market, regional snapshot 2019 & 2029
  • FIG 15. North America Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Pharmaceutical Contract Sales Organizations Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Pharmaceutical Contract Sales Organizations Market is valued at approximately USD 7.90 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.4% over the forecast period 2022-2029. In order to expand the production capacity for vaccinations and other efficient treatment alternatives, the pharmaceutical sector has come under scrutiny. These advances are being used by market participants in the pharmaceutical contract sales outsourcing (CSO) sector to meet consumer and healthcare facility demand. Another significant factor generating income prospects for industry participants in the pharmaceutical contract sales outsourcing (CSO) sector is the increased knowledge of the immune system's potential. A rising desire for lower in-house sales costs, a rise in pharmaceutical R&D activities, and a rising number of new medication launches are a few of the major drivers of the industry's expansion. Moreover, high government initiatives and rising geriatric population are creating a lucrative growth opportunity for the market over the forecast period 2022-2029.

Companies that make biopharmaceuticals are currently concentrating on enhancing their research capacities. Almost 45% of all drugs in development in 2022, as per the Pharma R&D annual review, were biopharmaceuticals. It is anticipated that biopharmaceutical companies will outsource their sales activities to CSOs so they may concentrate on their research capabilities due to the great interest these companies have in research. However, the high cost of Pharmaceutical Contract Sales Organizations stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pharmaceutical Contract Sales Organizations Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2022, North America had the largest market share, accounting for approximately 34.45% of global industry revenue. One of the main factors promoting the region's growth is the existence of a sizable number of CSOs there, including IQVIA, Inc., EPS Corp., and Axxelus. The demand for pharmaceutical CSOs is further supported by the region's embrace of new technology for pharmaceutical sales and a sizable number of new drug launches in the area. During the projected period, the Asia Pacific region is anticipated to increase at the fastest rate. The demand for CSO operations in the region is rising as a result of the substantial number of pharmaceutical and biopharmaceutical businesses in the area that are consistently developing novel treatments. In comparison to other developed areas, the region offers CSO services at a lower cost; this is anticipated to improve CSO activities and assist the sector market.

Major market players included in this report are:

  • CMIC Holdings Co., Ltd.
  • Axxelus
  • EPS Corp.
  • QFR Solutions
  • MaBico
  • Mednext Pharma Pvt. Ltd.
  • Peak Pharma Solutions Inc.
  • IQVIA, Inc.
  • Promoveo Health
  • Syneous Health

Recent Developments in the Market:

  • Dr Reddy's Laboratories and IQVIA, Inc. entered a partnership in September 2022. In accordance with the agreement, IQVIA gave Dr Reddy access to its Orchestrated Customer Engagement (OCE) platform to support its CRM activities. According to the deal, Dr Reddy gave IQVIA's OCE application to all of its marketing users and field staff in India so they could more effectively engage customers by integrating marketing, account management, medical scientific liaison, sales, and other activities.

Global Pharmaceutical Contract Sales Organizations Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Service, End-use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Service offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Service:

  • Personal Promotion
  • Non-personal Promotion

By End-use:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Pharmaceutical Contract Sales Organizations Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Pharmaceutical Contract Sales Organizations Market, by Service, 2019-2029 (USD Billion)
    • 1.2.3. Pharmaceutical Contract Sales Organizations Market, by End-use, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pharmaceutical Contract Sales Organizations Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Contract Sales Organizations Market Dynamics

  • 3.1. Pharmaceutical Contract Sales Organizations Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing pharmaceutical R&D activities
      • 3.1.1.2. Growing drug development
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Pharmaceutical Contract Sales Organizations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. High government initiatives
      • 3.1.3.2. Rising geriatric population

Chapter 4. Global Pharmaceutical Contract Sales Organizations Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pharmaceutical Contract Sales Organizations Market, by Service

  • 6.1. Market Snapshot
  • 6.2. Global Pharmaceutical Contract Sales Organizations Market by Service, Performance - Potential Analysis
  • 6.3. Global Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts by Service 2019-2029 (USD Billion)
  • 6.4. Pharmaceutical Contract Sales Organizations Market, Sub Segment Analysis
    • 6.4.1. Personal Promotion
    • 6.4.2. Non-personal Promotion

Chapter 7. Global Pharmaceutical Contract Sales Organizations Market, by End-use

  • 7.1. Market Snapshot
  • 7.2. Global Pharmaceutical Contract Sales Organizations Market by End-use, Performance - Potential Analysis
  • 7.3. Global Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts by End-use 2019-2029 (USD Billion)
  • 7.4. Pharmaceutical Contract Sales Organizations Market, Sub Segment Analysis
    • 7.4.1. Pharmaceutical Companies
    • 7.4.2. Biopharmaceutical Companies

Chapter 8. Global Pharmaceutical Contract Sales Organizations Market, Regional Analysis

  • 8.1. Pharmaceutical Contract Sales Organizations Market, Regional Market Snapshot
  • 8.2. North America Pharmaceutical Contract Sales Organizations Market
    • 8.2.1. U.S. Pharmaceutical Contract Sales Organizations Market
      • 8.2.1.1. Service breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-use breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Pharmaceutical Contract Sales Organizations Market
  • 8.3. Europe Pharmaceutical Contract Sales Organizations Market Snapshot
    • 8.3.1. U.K. Pharmaceutical Contract Sales Organizations Market
    • 8.3.2. Germany Pharmaceutical Contract Sales Organizations Market
    • 8.3.3. France Pharmaceutical Contract Sales Organizations Market
    • 8.3.4. Spain Pharmaceutical Contract Sales Organizations Market
    • 8.3.5. Italy Pharmaceutical Contract Sales Organizations Market
    • 8.3.6. Rest of Europe Pharmaceutical Contract Sales Organizations Market
  • 8.4. Asia-Pacific Pharmaceutical Contract Sales Organizations Market Snapshot
    • 8.4.1. China Pharmaceutical Contract Sales Organizations Market
    • 8.4.2. India Pharmaceutical Contract Sales Organizations Market
    • 8.4.3. Japan Pharmaceutical Contract Sales Organizations Market
    • 8.4.4. Australia Pharmaceutical Contract Sales Organizations Market
    • 8.4.5. South Korea Pharmaceutical Contract Sales Organizations Market
    • 8.4.6. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market
  • 8.5. Latin America Pharmaceutical Contract Sales Organizations Market Snapshot
    • 8.5.1. Brazil Pharmaceutical Contract Sales Organizations Market
    • 8.5.2. Mexico Pharmaceutical Contract Sales Organizations Market
  • 8.6. Rest of The World Pharmaceutical Contract Sales Organizations Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. CMIC Holdings Co., Ltd.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Axxelus
    • 9.2.3. EPS Corp.
    • 9.2.4. QFR Solutions
    • 9.2.5. MaBico
    • 9.2.6. Mednext Pharma Pvt. Ltd.
    • 9.2.7. Peak Pharma Solutions Inc.
    • 9.2.8. IQVIA, Inc.
    • 9.2.9. Promoveo Health
    • 9.2.10. Syneous Health

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption